Thousands with Sjögren's are seeing real, documented change in symptoms they were told were permanent.



For as long as it has had a name, Sjögren's has been treated as a dryness problem.
Dry eyes. Dry mouth. Use the drops. Drink more water. "It's mild." "It's a nuisance condition, not a serious one." "You're a working mother with teenagers, of course you're tired." "Your labs are normal." "That part is probably fibromyalgia." The same short list of answers, handed to millions of people whose bodies feel cemented every morning, whose knees stop bending somewhere between the bed and the bathroom, and whose feet burn every night — all of them built on one assumption: that if the eyes are dry and the mouth is dry, the disease lives in the eyes and the mouth, and everything else is something else.
But dry eyes don't explain the fatigue that nine hours of sleep doesn't touch. Dry mouth doesn't explain the morning stiffness, the joint pain that moves from the wrists to the hips, the knees that negotiate every stair, the burning in the feet, or the word that vanishes mid-sentence. Something has to be producing all of it. A gland problem was never really an explanation for a whole-body illness — it was the best medicine could do with an incomplete picture.
In 2026, that picture is finally starting to look more complete.
Thousands with Sjögren's are finally getting their lives back — the version of themselves they were before the diagnosis, before the drops and the lozenges and the humidifier on the nightstand — not through another prescription, not through another protocol, but through a discovery that traces back to what the body did to one specific tissue when the immune system switched on — and never switched off. It went into survival mode, it pulled supply from that tissue to fund the fight, and the change it left behind never resolved on its own — quietly producing every symptom that defines Sjögren's ever since. It was never visible on a standard test, because no standard test was ever designed to look at the tissue where it happened.
And once that finding is understood, Sjögren's stops looking like a gland problem with a dozen unrelated side effects — and starts looking like one problem, in one tissue, with a real path forward.
What the Research Actually Found
There is a reason every test kept coming back normal — and it is not the reason patients were given.
A Schirmer strip measures how many tears the eye produces in five minutes. A salivary flow test measures how much saliva the mouth produces in fifteen. Bloodwork looks for two antibodies — and comes back negative in nearly one in three people who have the disease. A lip biopsy takes a piece of the gland itself and counts the immune cells inside it. And when the knees hurt, an X-ray photographs the bone — and comes back with the same five words: mild wear, normal for age.
Every standard test a Sjögren's patient has ever been given was built to examine one thing at a time — the tears, the saliva, the blood, the gland, the bone.
None of them were built to examine the tissue all of those things sit in.
Most people with Sjögren's have already been told what's wrong. That their immune system is attacking the glands that make tears and saliva. That the glands are scarring — "fibrosis." That the disease is systemic, that it goes beyond the glands, that it causes fatigue and joint pain and nerve symptoms too.
All of that is right.
What nobody told them is why. Why a gland disease produces exhaustion that nine hours of sleep doesn't touch. Why it produces a body that wakes up cemented. Why the knees stop working before the coffee is ready. Why the feet burn. And why the dryness and the fatigue and the stiffness all arrived together — and never left.
The answer is a tissue called fascia — the water-rich layer of connective tissue that runs through the entire body as one continuous sheet.
Fascia wraps every muscle. It holds nearly every nerve in place. It runs alongside every blood vessel, from the scalp to the soles of the feet — and it forms the sleeve that surrounds every joint, thickest of all around the knee, the largest load-bearing junction in the body. In a healthy body it is soft, hydrated, and slippery, a wet cushion around everything it wraps.
Nothing is felt from it, because nothing is supposed to be. It is invisible by design. And it stays that way for one reason: the body continuously supplies it with what it needs to hold water.
Two things about this tissue matter more for Sjögren's than for any other condition.
First: fascia is the body's water reservoir. It is the largest water-holding tissue in the body — it holds water through a single molecule, hyaluronic acid, that binds hundreds of times its own weight in water between the tissue's layers.
Which matters, because the tear glands and the saliva glands sit inside it. Glands don't make water. They draw it from the tissue around them, through vessels that run through that tissue, on a nerve signal that runs through that tissue. The gland is the tap. The fascia is the tank.
Second: over the last several years, research groups in Europe have begun examining the connective tissue of Sjögren's patients directly — not the glands, but the tissue around the tendons and the soles of the feet — and found it measurably thickened compared to healthy people. The tissue is changing body-wide. The glands are just the part that was being measured.
Which raises the question every patient asks next. What happens to that tissue when the immune system switches on and never switches off?
The answer starts with the trigger.
Most people with Sjögren's can name the season it started. A virus — mono, the flu, and since 2020, overwhelmingly COVID. A pregnancy. The years around menopause. A stretch of caregiving or grief that ran the body into the ground. Something that put the body into survival mode — the same emergency response every human body runs during a serious threat.
In Sjögren's, that emergency doesn't end. The immune system stays switched on. Researchers can measure it directly — the majority of Sjögren's patients carry a pattern in their blood called an interferon signature, the same chemical state the body runs during an active viral infection. Except there is no virus. The body is fighting, around the clock, for years.
And during survival mode, the body does something it has done for as long as there have been human bodies. To fuel the fight, it redirects its nutrient supply toward the organs it cannot afford to lose — the heart, the lungs, the brain — pulling it away from everything it can afford to run lean for a few weeks.
This is not new science. It has been an accepted, well-mapped part of human physiology for four decades. Every human body does it. Every human body is supposed to.
Fascia is one of the first places that supply gets pulled from.
For most people, this is invisible and temporary. The virus clears, the body switches out of survival mode, full supply to the fascia resumes, and nothing lasting happens.
In Sjögren's, the switch never flips back.
The immune system stays on. The body stays in survival mode. And the fascia keeps running on a fraction of what it needs — for years. Month by month, the body's water reservoir dries out. The hyaluronic acid inside it — the molecule that should be a slippery lubricant — thickens into a dense, sticky gel. The tissue stiffens. It densifies.
And a densified reservoir does three things at the same time.
The tank runs dry. The gland is still trying to draw water from the tissue around it. There is less water in that tissue to draw. So the tears thin. The saliva thins. Not because the tap broke — because the tank it draws from is empty.
The tissue closes in. As the fascia hardens, it presses on whatever runs through it — the gland and its ducts, the tendon sheaths, the sleeve around the joint. This is the "fibrosis" every Sjögren's patient has heard their rheumatologist mention. It is also why the prescription pills that force the glands to work — Salagen, Evoxac — stop working after a while. Once the tissue around the gland has hardened, stimulating the gland doesn't help. There is nothing left to push through.
The signal gets choked. The nerves that run through the same tissue get pressed flat inside it. The instruction to make tears, to make saliva, gets physically muffled on the way to the gland. And around the knee, the pressed nerves start firing on their own — pain where there is no injury, burning where there is no heat.
So the eyes and the mouth aren't failing glands. They're glands sitting in a dried, hardened bed — with their supply cut off and their signal choked.
And here is the part that changes everything: the fascia doesn't stop at the glands. It is one continuous sheet. The same densified layer that is closing in on the tear glands is closing in on the muscles, the nerves, the vessels, and the joint sleeves everywhere else in the body — doing the same thing to them that it is doing to the glands.
Nowhere does this cost more than in the knees.
The knee carries the thickest load-bearing fascia in the body, and it is the joint you ask the most of — every stair, every chair, every time you kneel to the floor. And around a joint that bears load, densified fascia starts something worse than stiffness. It starts a loop.
The hardened tissue presses. The muscles around the joint clamp down to protect it — an ancient reflex called guarding. The clamping chokes the local blood flow further. Starved of circulation, the cells run out of energy — and a tissue without energy cannot rebuild its water-holding molecules, so it densifies faster. Which presses harder. Which tightens the guarding. Pain, lockdown, no blood, no energy, more pain. Each turn of the loop makes the next one easier.
That is why the knee of a Sjögren's patient so often looks fine on the X-ray and feels like gravel wrapped in a vice — and why, on its own, it never resolves.
And because fascia is wired into the nervous system, densified fascia doesn't just press. It fires. A constant stream of activation signals telling the body it's under threat — from the tissue itself. The body can't leave survival mode because the tissue keeps telling it there's an emergency — and the tissue keeps densifying because the body is locked in survival mode.
Which is why, on its own, it never resolves. Why the dryness and the fatigue and the stiffness and the burning all started at the same time. And why every symptom a Sjögren's patient lives with traces back to the same place.
For the roughly one in three people with Sjögren's who have also been handed a fibromyalgia diagnosis — often before the Sjögren's was found — this is worth sitting with. The same tissue finding is now being examined in fibromyalgia. It was never two diseases. It was one tissue, doing the same thing, given two names.
Why Every Symptom Finally Makes Sense
Sjögren's has always looked like a disease that doesn't add up. Dry eyes and burning feet. Dry mouth and knees that wake up older than you are. Dryness and exhaustion. Symptoms that seem to have nothing to do with each other — the ones patients have been told are fibromyalgia, or menopause, or stress, or age. Once the finding is understood, they stop looking random. Not a dozen unrelated problems. One problem, showing up in a dozen places.
The glands aren't broken. They're sitting in a reservoir that has run dry, inside tissue that has hardened around them, with the nerve signal that tells them to work pressed flat. Every drop, every lozenge, every liter of water goes to the surface — and the tissue underneath, the tissue the gland actually draws from, never gets any of it. Which is why nothing lasts longer than twenty minutes.
Fascia wraps every muscle, every tendon sheath, and every joint — and nowhere is it thicker than around the knee. Overnight, without movement, densified fascia settles and stiffens further — so the body wakes inside a layer that has to be warmed and worked loose before anything moves. And because fascia is one continuous sheet, where it presses hardest changes with load and position: the knee after yesterday's stairs, the wrist after this morning's typing. The tissue is the same. The pressure point moves.
Sleep only restores the body under one condition: the nervous system has to leave fight-or-flight and drop into rest mode. A Sjögren's body never gets there. The immune system is running a viral emergency around the clock, and the densified fascia is firing activation signals all night. So the body stays in survival mode through eight hours of sleep — and wakes up having recharged nothing. Sleep still happens. Rest doesn't.
Fascia holds nearly every nerve in the body in place — it is the sheath the nerves run through. When that sheath dries out and hardens, it presses on the nerves inside it — and the smallest nerves, the ones in the feet and calves, are the first to feel it. A nerve under constant pressure doesn't go quiet. It misfires. Burning where there is no heat. Tingling where there is no touch. The nerve conduction study comes back normal because it measures the large nerves. The small ones — the ones being pressed — are below its reach.
The brain recharges the same way the body does — during real rest — and a Sjögren's brain never gets any. Every night spent locked in survival mode is another night the brain doesn't recover. So it wakes up every morning at 10% battery and spends the day trying to find words on it.
For years, Sjögren's patients have been told it's just dry eyes. Told it's mild. Told the fatigue is menopause, the stiffness is fibromyalgia, the knees are just age, the burning is anxiety. Told their labs were normal so there was nothing to treat. Left to explain to husbands, employers, and dentists why a "dryness condition" has taken the life they had — while their doctors told them the tests were fine.
Now, for the first time, every symptom above is explained by the same finding — a single densified layer of fascia, doing the same thing everywhere in the body at once.
Not a gland problem with side effects. Not a mystery. Not something in their heads. Not something more eye drops would have fixed.
One tissue, in one state, producing everything they have been living with — and everything they have been trying to explain — for years.
Why Nothing on the Standard Shelf Has Ever Worked
Most people who have had Sjögren's for any length of time have cycled through the standard shelf.
Systane. Refresh. Restasis. Xiidra at $600 a bottle. Punctal plugs. Salagen. Evoxac and the sweating that comes with it. Biotène. Xylitol lozenges. Plaquenil. Prednisone. Methotrexate. LDN. Omega-3 by the handful. Sea buckthorn. Hyaluronic acid drops. The humidifier. And a dentist's estimate for $8,000 of crowns.
And for the knees, a second shelf. The brace from the pharmacy aisle. Capsaicin cream. Ice packs. NSAIDs by the handful. The cortisone shot that worked for nine days. The physical therapy you couldn't always get to.
And every one of them comes with the same pattern. A small shift — twenty, thirty percent. A plateau. Then a flare, or a cold, or a dry winter, and back to where things started.
The reason is simple: every one of them is aimed at the gland, at the immune markers, or at the bone.
Drops wet the surface for twenty minutes. Plugs keep what little the eye makes from draining away. Salagen and Evoxac force the gland to squeeze out whatever it has left. Plaquenil turns the immune markers down — and in the largest placebo-controlled trial ever run on it, 17.9% of patients improved on the drug and 17.2% improved on the sugar pill. And the brace holds still a tissue that is dying of stillness. The cream sinks two millimeters into a problem that runs three centimeters deep. The painkiller mutes the signal while the loop that produces it keeps tightening.
Every treatment on both shelves was designed to push on the output — the tears, the saliva, the antibodies, the pain signal — and none of them were aimed at the tissue everything sits in. The fascia is still densified around the glands. It is still pressing on the muscles and the nerves. It is still wrapped, hardened, around the knee. Everything producing the symptoms is still running underneath.
It is like moisturizing the surface of a sponge that has dried out all the way through — and wondering why it's dry again by morning.
What Finally Reaches the Real Problem
Which raised the obvious question.
If the fascia is densified — and if nothing on the standard shelf has ever been aimed at the fascia — then the real answer is not another drop, another lozenge, another prescription aimed at the gland. And it is not another brace, another cream, or another pill aimed at the bone.
The real answer is to give the fascia back what survival mode took from it — its water and its glide — and to break the loop that keeps re-densifying it, directly in the place where it is taking your life.
Not by swallowing something and hoping it arrives. By restoring the tissue itself — from the outside in, right where the densification hurts most.
The problem is that the science of fascia is very new. Almost no serious research existed on this tissue until the last five years. And none of it had ever been directed at the question that matters most — what does it actually take to return densified fascia to its soft, hydrated, gliding state?
The question itself was newer than the field's ability to answer it.
The Turning Point Came in 2026
That is finally changing.
In early 2025, a small group of clinicians and bioengineers were watching the Sjögren's research come in — the interferon signature, the thickened tissue on ultrasound, the fibrosis closing in on the glands, the trial data showing the standard prescription doing nothing for the symptoms that matter — and realized something that didn't make sense.
The research had identified the tissue. And in two other fields — rehabilitative medicine and photomedicine — the inputs that reverse densification had already been documented, one by one. Sustained therapeutic warmth, which returns the thickened hyaluronan gel to its fluid, lubricating state and reopens the microcirculation survival mode had cut. Mechanical vibration, which works the hardened layers loose and pumps stagnant fluid out of the tissue so fresh fluid can move in. And specific wavelengths of red and near-infrared light, studied for decades in tissue repair, which restart energy production inside the cells — including the fibroblasts, the very cells that manufacture hyaluronic acid, the molecule fascia uses to hold water.
Every piece existed.
And no one had built anything with it. Millions of people with Sjögren's, a documented finding in their tissue, and not a single product on the market designed to restore it where it disables them most — because the Sjögren's world was building eye drops and immune drugs, and the tissue researchers weren't building anything for the knee.
So rather than wait for someone else, they decided to be first.
They founded a company called Revornyn Health, and spent the better part of two years on the engineering — fourteen prototypes, calibrating the exact temperature the tissue responds to, the pulse rhythm that keeps working even where circulation is compromised, and the two light wavelengths with the deepest reach into the tissue around a joint.
What came out of it is called the ThermaKnee 360 — the first device built specifically to restore densified fascia where it disables people most: the knee.
In early 2026, Revornyn released the first production run of the ThermaKnee 360 to an initial group of adults with Sjögren's — every one of them at least two years past diagnosis, every one having already worked through the drops, the pills, the braces, and at least one injection — and tracked their mornings across a 90-day window.
By day 90, the numbers that came back changed how the researchers understood the finding itself.
The Real-World Results
The group was chosen deliberately. Every participant had been, before Sjögren's, some version of the same person: a capable, busy adult in the middle of her life. Nurses. Teachers. Managers. Mothers of teenagers. People who had never once thought about how much water was in their tissue. They enrolled at various points in the condition — some two years in, some diagnosed in their thirties — and all of them had done the standard rounds. Over the first 90 days, the participants reported the following.
But the number the researchers behind the project were watching most closely — was a different one:
Not managing. Not coping. The person they were before the diagnosis — coming back.
Every response came from a real person filling out a form on their phone, in their own words, on their own time.
Inside the Device
The ThermaKnee 360 was built around the three inputs research has documented as central to fascial restoration — delivered at the same time, in one cordless wrap, in a sequence the engineers call LoopBreaker™, because it interrupts the loop at all three of its points at once.
Medical-grade components · Third-party tested · Auto shut-off at 15 minutes
Safe alongside everything already in the protocol.
The ThermaKnee 360 is compatible with everything currently used for Sjögren's — Plaquenil, Restasis, Xiidra, Salagen, Evoxac, prednisone, methotrexate, LDN, punctal plugs, and every drop, gel, and lozenge on the nightstand — and every brace, cream, and ice pack in the drawer. Because it works on the tissue directly, there is no need to come off anything to begin. It does not compete with anything aimed at the glands or the immune markers — it restores the tissue those treatments were never aimed at, in the place they never reached. Anyone with a pacemaker, an active joint infection, or a recent knee surgery should check with their physician first, as with any therapeutic device.
Most people start the ThermaKnee 360 alongside whatever they've been taking, and let the fascia respond.
Most protocols for Sjögren's ask patients to manage more. The ThermaKnee 360 asks for fifteen minutes.
If a device shortens the morning, softens the stairs, and lets the body stand down in the majority of adults who have already tried everything on the standard shelf — standing behind it should not be complicated.
Use the ThermaKnee 360 every day for 90 days. If by the end of it you have not felt a real difference — if the first morning you swing your legs out of bed without negotiating with your knees never arrives — you get a full refund. No shipping the wrap back. No forms to fill out justifying the decision. No conditions.
The window mirrors the 90 days that the tracked group covered — the same window in which the majority of participants saw meaningful movement in mornings they had been losing for years.
Why Starting Sooner Matters
The state the fascia is in runs in one direction.
Every flare the fascia never fully recovers from is more densification. Every layer of densification is a tighter squeeze on the glands, the nerves, and the tendon sheaths. Every tightening drops the supply further. Which produces more densification. Which produces more flares. Which produces less recovery between them.
That is what sits behind what patients describe as their baseline dropping — quietly, year over year — without anything they try interrupting it. The winter that used to mean a rough month now means a rough season. The drops that used to last an hour now last fifteen minutes. The stairs that used to be nothing become the thing you plan your day around. The Salagen that used to help doesn't anymore — because the tissue it was pushing against has hardened past what it can move.
And it is why "it's mild, it won't progress" so rarely holds. In long-term follow-up, the majority of people with Sjögren's develop systemic involvement over five to fifteen years — the neuropathy, the fatigue, the stiffness arriving one after another. The body doesn't stay mild in a tissue that keeps hardening. It grows into it.
The fascia today is the most responsive it will ever be. Every month it goes unaddressed, that changes.
ThermaKnee 360 Is Not Sold on Amazon
The ThermaKnee 360 is only available at getrevornynhealth.com. If it shows up anywhere else, it isn't the real thing. Here's what's going on:
Scammers have listed lookalike "heated knee massagers" copying the name and the product photos. These counterfeits are made with uncalibrated heating elements and decorative red LEDs — not therapeutic wavelengths. They get warm. They do nothing to the tissue. Many are never shipped at all — buyers are charged and receive nothing. Unfortunately, real customers have already been scammed this way. Revornyn Health is actively working to get these listings removed.
The genuine, calibrated ThermaKnee 360 is sold in one place only: getrevornynhealth.com
From People Who Had Stopped Expecting Anything to Move
About three weeks in I noticed I was downstairs before the kettle boiled. Didn't even register why at first. Now I take the stairs without planning them. Still use my drops, still have my days. Not cured, I know that's not how this works, but I'm functioning and I'd stopped expecting to.
Somebody in the Sjögren's group posted this and the part about the tissue drying and hardening around everything was the first explanation that covered all of it — the eyes AND the knees AND the exhaustion. Six weeks in. The stairs are just stairs now, and my knees don't wake me at night. My husband said I laughed at dinner and he hadn't heard that in a while.
Three months on this. I'm not going to say I have my old knees. But last Saturday I got down on the floor with my granddaughter's puzzle, stayed for the whole thing, and got back up by myself. That's the review.
Practitioner allocation first
The last thing worth knowing is that the ThermaKnee 360 is not always in stock.
It is assembled in small, calibrated batches — every heating element, pulse motor, and light array is tested to specification before it ships. A portion of every batch is reserved for the physicians, rheumatology practices, and physical therapists who recommend it within their clinics. Whatever remains is released to the public, first-come, first-served.
When a batch sells out, the next one takes six to eight weeks to produce, and customers already on the protocol are placed ahead of new customers for restocks.
But if the ThermaKnee 360 is in stock, this is an invitation to join the more than 19,000 people who are already using it.
